JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) Fundamental Analysis & Valuation

NASDAQ:NAMI • US47760D1028

Current stock price

0.5258 USD
+0 (+0.9%)
Last:

This NAMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NAMI Profitability Analysis

1.1 Basic Checks

  • In the past year NAMI was profitable.
NAMI Yearly Net Income VS EBIT VS OCF VS FCFNAMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • With a decent Return On Assets value of 8.30%, NAMI is doing good in the industry, outperforming 79.45% of the companies in the same industry.
  • NAMI has a better Return On Equity (16.95%) than 80.82% of its industry peers.
  • NAMI has a better Return On Invested Capital (13.77%) than 87.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NAMI is significantly above the industry average of 15.17%.
  • The last Return On Invested Capital (13.77%) for NAMI is well below the 3 year average (46.99%), which needs to be investigated, but indicates that NAMI had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.3%
ROE 16.95%
ROIC 13.77%
ROA(3y)30.62%
ROA(5y)N/A
ROE(3y)91.51%
ROE(5y)N/A
ROIC(3y)46.99%
ROIC(5y)N/A
NAMI Yearly ROA, ROE, ROICNAMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 50 100 150

1.3 Margins

  • NAMI's Profit Margin of 4.99% is fine compared to the rest of the industry. NAMI outperforms 63.01% of its industry peers.
  • Looking at the Operating Margin, with a value of 6.67%, NAMI is in the better half of the industry, outperforming 60.27% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 28.78%, NAMI is doing worse than 67.12% of the companies in the same industry.
Industry RankSector Rank
OM 6.67%
PM (TTM) 4.99%
GM 28.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAMI Yearly Profit, Operating, Gross MarginsNAMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NAMI Health Analysis

2.1 Basic Checks

  • NAMI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • NAMI has less shares outstanding than it did 1 year ago.
  • NAMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAMI Yearly Shares OutstandingNAMI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M
NAMI Yearly Total Debt VS Total AssetsNAMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 2.61 indicates that NAMI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of NAMI (2.61) is better than 67.12% of its industry peers.
  • NAMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.61
ROIC/WACC1.83
WACC7.54%
NAMI Yearly LT Debt VS Equity VS FCFNAMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that NAMI should not have too much problems paying its short term obligations.
  • NAMI's Current ratio of 1.67 is fine compared to the rest of the industry. NAMI outperforms 64.38% of its industry peers.
  • A Quick Ratio of 1.62 indicates that NAMI should not have too much problems paying its short term obligations.
  • The Quick ratio of NAMI (1.62) is better than 67.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.62
NAMI Yearly Current Assets VS Current LiabilitesNAMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NAMI Growth Analysis

3.1 Past

  • The earnings per share for NAMI have decreased strongly by -35.15% in the last year.
  • Looking at the last year, NAMI shows a small growth in Revenue. The Revenue has grown by 7.00% in the last year.
EPS 1Y (TTM)-35.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAMI Yearly Revenue VS EstimatesNAMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100M 200M 300M 400M

More info and screens

Find the best growth stocksShow best growing peers

3

4. NAMI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.26, the valuation of NAMI can be described as very cheap.
  • 94.52% of the companies in the same industry are more expensive than NAMI, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of NAMI to the average of the S&P500 Index (26.21), we can say NAMI is valued rather cheaply.
Industry RankSector Rank
PE 5.26
Fwd PE N/A
NAMI Price Earnings VS Forward Price EarningsNAMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 95.89% of the companies in the same industry are more expensive than NAMI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.2
NAMI Per share dataNAMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NAMI Dividend Analysis

5.1 Amount

  • No dividends for NAMI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NAMI Fundamentals: All Metrics, Ratios and Statistics

JINXIN TECHNOLOGY HOLDIN-ADR

NASDAQ:NAMI (4/7/2026, 8:54:17 PM)

0.5258

+0 (+0.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)12-22
Earnings (Next)04-13
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap35.95M
Revenue(TTM)406.40M
Net Income(TTM)20.27M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.26
Fwd PE N/A
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 2.06
P/tB 4.69
EV/EBITDA 3.2
EPS(TTM)0.1
EY19.02%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.87
BVpS0.26
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.76
Profitability
Industry RankSector Rank
ROA 8.3%
ROE 16.95%
ROCE 17.43%
ROIC 13.77%
ROICexc 17.55%
ROICexgc 38.89%
OM 6.67%
PM (TTM) 4.99%
GM 28.78%
FCFM N/A
ROA(3y)30.62%
ROA(5y)N/A
ROE(3y)91.51%
ROE(5y)N/A
ROIC(3y)46.99%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)59.48%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.62
Altman-Z 2.61
F-ScoreN/A
WACC7.54%
ROIC/WACC1.83
Cap/Depr(3y)131.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-182%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.56%
OCF growth 3YN/A
OCF growth 5YN/A

JINXIN TECHNOLOGY HOLDIN-ADR / NAMI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JINXIN TECHNOLOGY HOLDIN-ADR?

ChartMill assigns a fundamental rating of 4 / 10 to NAMI.


What is the valuation status for NAMI stock?

ChartMill assigns a valuation rating of 3 / 10 to JINXIN TECHNOLOGY HOLDIN-ADR (NAMI). This can be considered as Overvalued.


How profitable is JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) stock?

JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) has a profitability rating of 5 / 10.


How financially healthy is JINXIN TECHNOLOGY HOLDIN-ADR?

The financial health rating of JINXIN TECHNOLOGY HOLDIN-ADR (NAMI) is 7 / 10.